PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Statin guidelines miss middle-age patients and over-target seniors

2015-03-12
(Press-News.org) DURHAM, N.C. - The newest guidelines for the use of cholesterol-lowering statins in people at risk of heart disease may be too generic, excluding middle-aged adults who could benefit from the drugs, and over-prescribing in older adults, according to a new study from the Duke Clinical Research Institute.

But small adjustments to guidelines could enable doctors to catch more people between the ages of 40 to 55 with premature heart disease, and prevent unnecessary medication for many adults over age 65, according to the analysis, published this month in the Journal of the American College of Cardiology.

"The recommendations appear to be one-size-fits-all for patients in a variety of groups," said Duke biostatistician Michael Pencina, Ph.D., a senior author of the paper. "We were interested in how tailoring the guidelines could get beneficial treatment to those who really need it, and avoid over-treating patients whose risk may only be their sex and age."

The statin guidelines have been debated since the American Heart Association and American College of Cardiology issued them in 2013, resulting in about 13 million new people being recommended for treatment, including most adults over 60.

The guidelines calculate a person's risk of developing heart disease in the next 10 years of their lives based on their age, sex, race, cholesterol and blood pressure, and whether they've been treated for high blood pressure or have smoked. According to the AHA/ACC guidelines, doctors should consider treating any patient whose 10-year risk is calculated at 7.5 percent or higher.

But after applying the new guidelines to 3,685 people who participated in a leg of the Framingham Heart Study that began in 1975, researchers found that basing treatment on a risk of 7.5 percent would have missed more than half of participants ages 40 to 55 who ended up with heart disease and may have benefited from statins.

On the other end of the spectrum, current guidelines would have over-recommended statins for adults over 60, a large portion of whom continued to be tracked and didn't develop heart disease in the following 10 years.

Current statin guidelines offer little flexibility. But shifting the treatment targets suggest better outcomes, said Ann Marie Navar-Boggan, M.D., a cardiology fellow at DCRI and the lead author of the paper.

"The guidelines don't perform particularly well in younger people," Navar-Boggan said. Lowering the treatment threshold for patients ages 40 to 55 to those with a 5 percent risk or greater could capture more middle-aged adults who develop heart disease early. But even at a 5 percent threshold, she said, the guidelines' risk-based recommendation is imperfect, failing to consider other factors such as family history when evaluating risk of heart disease.

For older adults, 97 percent of men over 65 would fall into the treatment category, many solely because of their age and sex. In this case, the 7.5 percent threshold may be too low, Navar-Boggan said.

"We found that by raising that threshold to 15 percent, the guidelines could identify the same proportion of men who will go on to have heart disease, but would reduce treatment for those who will not. This would help eliminate unnecessary drug treatment for many patients," she said.

The study has its limitations, the authors note, including using a population that lacked geographical and ethnic diversity. But they hope it will prompt further investigation and improvements for the next round of guidelines on statin use.

"To date, the guidelines haven't made variations in recommendations by age and sex," Navar-Boggan said. "The study shows we can potentially do better by tailoring guidelines to these groups."

INFORMATION:

In addition to Pencina and Navar-Boggan, study authors include Eric D. Peterson, Ralph B. D'Agostino, Sr.; and Allan D. Sniderman.

The researchers received funding from the Doggone Foundation and the Duke Clinical Research Institute.



ELSE PRESS RELEASES FROM THIS DATE:

Inflammation in the mouth and joints in rheumatoid arthritis

2015-03-12
Boston, Mass., USA - Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled "Inflammation in the Mouth and Joints in Rheumatoid Arthritis." The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting of the Canadian Association for Dental Research. Periodontitis shares pathogenic mechanisms with rheumatoid arthritis (RA) ...

Largest review of clinical trials to assess risk of patients using Champix

2015-03-12
Findings from the largest review of clinical trials to date to determine whether patients prescribed the smoking cessation drug Varenicline (brand name Champix in the UK) are at an increased risk of neuropsychiatric events are published online in the British Medical Journal [BMJ] today [12 Mar]. The drug, which was first licensed in the UK in 2006, has been shown to be the most clinically effective smoking cessation medicine for reducing nicotine cravings and withdrawal symptoms for short-term abstinence. However, since its introduction there have been concerns over its ...

Reaching '80 percent by 2018' would prevent more than 20,000 colorectal cancer deaths per year

2015-03-12
ATLANTA - March 12, 2015-Increasing colorectal cancer screening rates to 80% by 2018 would prevent an additional 21,000 colorectal cancer deaths per year by 2030, according to a new study. The study is the first to estimate the public health benefits of increasing screening rates to "80% by 2018," a recent initiative from the National Colorectal Cancer Roundtable (NCCRT), a national coalition of public, private, and voluntary organizations, to aim for screening rates of 80% in the United States by 2018. The study is co-authored by American Cancer Society epidemiologist ...

Study bolsters 'turbocharged' protein as a promising tool in hemophilia gene therapy

2015-03-12
Using gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated dogs with the bleeding disorder hemophilia, without triggering an unwanted immune response. In addition, the "turbocharged" clotting factor protein eliminated pre-existing antibodies that often weaken conventional treatments for people with hemophilia. "Our findings may provide a new approach to gene therapy for hemophilia and perhaps other genetic diseases that have similar complications from inhibiting antibodies," said the study leader, ...

Health law hasn't cut insurers' rate of overhead spending: Study

2015-03-12
Despite claims by the Obama administration that the Affordable Care Act will reduce health insurance companies' spending on overhead, thereby channeling a greater share of consumers' premium dollars into actual patient care, insurers' financial filings show the law had no impact on the percentage of insurer expenditures on such things as administration, marketing and profits. That's the chief finding of a team of researchers, including two prominent physicians on the faculties of the City University of New York's School of Public Health and Harvard Medical School, in ...

Mind reading thanks to metaphors

2015-03-12
Observe whether two people use metaphors in conversation with each other if you want to guess how close they are as friends. Or sharpen your ability to tune into other people's emotional or mental states by observing the metaphors they use. Why is this? Because metaphors can in fact help one to 'mind read,' report Andrea Bowes and Albert Katz of the University of Ontario in Canada in Springer's journal Memory & Cognition. Metaphor is a type of language that forms part of our daily conversations and communication. In this type of language, the literal or usual meaning ...

Social status has impact on overall health of mammals

Social status has impact on overall health of mammals
2015-03-12
EAST LANSING, Mich. - High social status has its privileges -- when it comes to aging -- even in wild animals. In a first-of-its-kind study involving a wild species, Michigan State University researchers have shown that social and ecological factors affect animal health. The results, published in the current issue of Biology Letters, focused on spotted hyenas in Kenya. "High-ranking members in hyena clans reproduce more, they live longer and appear to be in better overall health," said Nora Lewin, MSU doctoral student of zoology and co-lead author. "If you want to see ...

The ACA may reduce ER visits (slightly) but doesn't affect hospitalizations

2015-03-12
WASHINGTON - Two patient groups created by the Affordable Care Act (ACA) - Medicare patients enrolled in federally designated patient-centered medical homes and people under age 26 who are allowed to remain on their parents' health insurance - had slightly fewer emergency department visits than they had before health care reform. However, there was no change in the rate of the most expensive types of emergency visits: those that lead to hospitalization. One study examined the rate of emergency department visits and hospitalizations for Medicare patients treated by ...

Predicting which African storms will intensify into hurricanes

2015-03-12
Hurricanes require moisture, the rotation of the earth, and warm ocean temperatures to grow from a mere atmospheric disturbance into a tropical storm. But where do these storm cells originate, and exactly what makes an atmospheric disturbance amp up full throttle? A new study published in Geophysical Research Letters by Tel Aviv University's Prof. Colin Price and his graduate student Naama Reicher of the Department of Geosciences at TAU's Faculty of Exact Sciences finds most hurricanes over the Atlantic that eventually make landfall in North America actually start as ...

Engineers create chameleon-like artificial 'skin' that shifts color on demand

Engineers create chameleon-like artificial skin that shifts color on demand
2015-03-12
WASHINGTON, March 12, 2015--Borrowing a trick from nature, engineers from the University of California at Berkeley have created an incredibly thin, chameleon-like material that can be made to change color -- on demand -- by simply applying a minute amount of force. This new material-of-many-colors offers intriguing possibilities for an entirely new class of display technologies, color-shifting camouflage, and sensors that can detect otherwise imperceptible defects in buildings, bridges, and aircraft. "This is the first time anybody has made a flexible chameleon-like ...

LAST 30 PRESS RELEASES:

Protecting nature can safeguard cities from floods

NCSA receives honors in 2024 HPCwire Readers’ and Editors’ Choice Awards

Warning: Don’t miss Thanksgiving dinner, it’s more meaningful than you think

Expanding HPV vaccination to all adults aged 27-45 years unlikely to be cost-effective or efficient for HPV-related cancer prevention

Trauma care and mental health interventions training help family physicians prepare for times of war

Adapted nominal group technique effectively builds consensus on health care priorities for older adults

Single-visit first-trimester care with point-of-care ultrasound cuts emergency visits by 81% for non-miscarrying patients

Study reveals impact of trauma on health care professionals in Israel following 2023 terror attack

Primary care settings face barriers to screening for early detection of cognitive impairment

November/December Annals of Family Medicine Tip Sheet

Antibiotics initiated for suspected community-acquired pneumonia even when chest radiography results are negative

COVID-19 stay-at-home order increased reporting of food, housing, and other health-related social needs in Oregon

UW-led research links wildfire smoke exposure with increased dementia risk

Most U.S. adults surveyed trust store-bought turkey is free of contaminants, despite research finding fecal bacteria in ground turkey

New therapy from UI Health offers FDA-approved treatment option for brittle type 1 diabetes

Alzheimer's: A new strategy to prevent neurodegeneration

A clue to what lies beneath the bland surfaces of Uranus and Neptune

Researchers uncover what makes large numbers of “squishy” grains start flowing

Scientists uncover new mechanism in bacterial DNA enzyme opening pathways for antibiotic development

New study reveals the explosive secret of the squirting cucumber

Vanderbilt authors find evidence that the hunger hormone leptin can direct neural development in a leptin receptor–independent manner

To design better water filters, MIT engineers look to manta rays

Self-assembling proteins can be used for higher performance, more sustainable skincare products

Cannabis, maybe, for attention problems

Building a better path to recovery for OUD

How climate change threatens this iconic Florida bird

Study reveals new factor involved in controlling calorie expenditure

Managing forests with smart technologies

Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

H.E.S.S. collaboration detects the most energetic cosmic-ray electrons and positrons ever observed

[Press-News.org] Statin guidelines miss middle-age patients and over-target seniors